Welcome to CDC stacks | A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer - 30650 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
Filetype[PDF-2.41 MB]


Details:
No Related Documents.
You May Also Like:
  1. Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
    Personal Author:
    Dizon, Don S.; Krilov, Lada; Cohen, Ezra; Gangadhar, Tara; Ganz, Patricia A.; Hensing, Thomas A.; Hunger, Stephen; Krishnamurthi, Smitha S.; Lassman, Andrew B.; Markham, Merry Jennifer; Mayer, Erica; Neuss, Michael; Pal, Sumanta Kumar; Richardson, Lisa C.; Schilsky, Richard; Schwartz, Gary K.; Spriggs, David R.; Villalona-Calero, Miguel Angel; Villani, Gina; Masters, Gregory;
    Published:
    Feb 04 2016
    Source:
    J Clin Oncol. 34(9):987-1011.
    File Type:
    Filetype[PDF - 692.37 KB]
  2. Safe Handling of Oral Antineoplastic Medications: Focus on Targeted Therapeutics in the Home Setting
    Personal Author:
    Cass, Yaakov; Connor, Thomas H.; Tabachnik, Alexander;
    Published:
    Mar 22 2016
    Source:
    J Oncol Pharm Pract. 23(5):350-378.
    Description:
    Introduction : With the growing number of oral targeted therapies being approved for use in cancer therapy, the potential for long-term administration of these drugs to cancer patients is expanding. The use of these drugs in the home setting has the ...
    File Type:
    Filetype[PDF - 448.42 KB]
  3. HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia
    Personal Author:
    Akahane, Koshi; Sanda, Takaomi; Mansour, Marc R.; Radimerski, Thomas; DeAngelo, Daniel J.; Weinstock, David M.; Look, A. Thomas;
    Published:
    Aug 12 2015
    Source:
    Leukemia. 30(1):219-228.
    Description:
    We previously found that tyrosine kinase 2 (TYK2) signaling through its downstream effector phospho-STAT1 acts to upregulate BCL2, which in turn mediates aberrant survival of T-cell acute lymphoblastic leukemia (T-ALL) cells. Here we show that pharma...
    File Type:
    Filetype[PDF - 1.88 MB]
  4. Wnt signaling in triple negative breast cancer is associated with metastasis
    Personal Author:
    Dey, Nandini; Barwick, Benjamin G; Moreno, Carlos S; Ordanic-Kodani, Maja; Chen, Zhengjia; Oprea-Ilies, Gabriella; Tang, Weining; Catzavelos, Charles; Kerstann, Kimberly F; Sledge, George W; Abramovitz, Mark; Bouzyk, Mark; De, Pradip; Leyland-Jones, Brian R;
    Published:
    Nov 10 2013
    Source:
    BMC Cancer. 2013; 13:537.
    Description:
    Background : Triple Negative subset of (TN) Breast Cancers (BC), a close associate of the basal-like subtype (with limited discordance) is an aggressive form of the disease which convey unpredictable, and poor prognosis due to limited treatment optio...
    File Type:
    Filetype[PDF - 1.82 MB]
  5. Bacterial Adaptation through Loss of Function
    Personal Author:
    Hottes, Alison K.; Freddolino, Peter L.; Khare, Anupama; Donnell, Zachary N.; Liu, Julia C.; Tavazoie, Saeed;
    Published:
    Jul 11 2013
    Source:
    PLoS Genet. 2013; 9(7).
    Description:
    The metabolic capabilities and regulatory networks of bacteria have been optimized by evolution in response to selective pressures present in each species' native ecological niche. In a new environment, however, the same bacteria may grow poorly due ...
    File Type:
    Filetype[PDF - 1.98 MB]